Illumina Sequencing Revenue Grows 70 Percent in Q4, Driven by HiSeq
February 15, 2011
Illumina Sequencing Revenue Grows 70 Percent in Q4, Driven by HiSeq
During a conference call to discuss the company's earnings, Illumina representatives outlined plans for the MiSeq platform, Epicentre products, and refurbished Genome Analyzers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.